CJC + IPA 10mg

CJC-1295 (no DAC) + Ipamorelin is a synthetic research peptide blend commonly explored for its interaction with growth hormone signalling pathways. CJC-1295 is a growth hormone-releasing hormone analogue studied for its ability to increase growth hormone and IGF-1 activity while preserving pulsatile secretion patterns, whereas Ipamorelin is a selective growth hormone secretagogue investigated for stimulating growth hormone release with greater selectivity than earlier compounds of its class (Raun et al., 1998; Teichman et al., 2006; Ionescu et al., 2006). In research settings, this peptide category is typically examined in relation to endocrine signalling, metabolic regulation, and repair-signalling mechanisms. Supplied as a lyophilised powder, this product is intended strictly for laboratory research use only. It is not approved for human consumption, and published clinical evidence on the exact combined formulation remains limited.